Portfolio: Highlights

MPM invests in biotechnology, specialty pharma, medical technology, and related companies that provide innovative medical products and requisite services to the healthcare industry -- irrespective of geography, stage of development and therapeutic area.

EKR Holdings, Inc.
Pain management and oncology products

Pacira Pharmaceuticals, Inc.
Sustained-release drug delivery technologies

Peplin Limited
Development and commercialisation of prescription therapeutic products for cancer patients

TriVascular2, Inc.
Novel endovascular repair devices to treat abdominal aortic aneurysms

BioMarin Pharmaceuticals
Biopharmaceuticals for serious diseases and medical conditions

Biovitrum AB
Biopharmaceuticals for metabolic & blood disorders

Caliper Technologies Corp.
Cutting edge technologies for life science researchers.

Idenix Pharmaceuticals, Inc.
Anti-HIV and HBV therapy

Intercell AG
Vaccines for the prevention and treatment of infectious diseases.

Omrix Biopharmaceuticals, Inc.
Innovative biosurgical and passive immunotherapy products

Pharmasset, Inc.
Exited via the public markets

Rigel
Novel small-molecule drugs for inflammatory/autoimmune diseases and cancer.

ViaCell
Acquired by PerkinElmer

CoTherix
Acquired by Actelion

HemoSense
Acquired by Inverness Medical Innovations

Hypnion
Acquired by Lilly

Idenix Pharmaceuticals, Inc.
Groundbreaking partnership with Novartis

IDUN Pharmaceuticals, Inc.
Early acquisition by Pfizer

Rinat Neuroscience Corp.
Genentech spinout acquired by Pfizer

TransForm
Acquired by J&J

ViaCell
Acquired by PerkinElmer